WHO Estimates 39%-89% Breast Cancer Survival Across 194 States, Exposing Global Gaps
Updated
Updated · Nature.com · Jul 8
WHO Estimates 39%-89% Breast Cancer Survival Across 194 States, Exposing Global Gaps
3 articles · Updated · Nature.com · Jul 8
Summary
WHO modeled age-standardized 5-year breast cancer survival for women diagnosed in 2017–2021 in all 194 member states, setting a global benchmark for tracking outcomes.
Median survival ranged from 39.1% in Africa to 88.5% in the Americas, with Europe at 84.0%, the Western Pacific at 81.1%, South-East Asia at 66.3% and the Eastern Mediterranean at 61.0%.
Income tracked outcomes closely: median survival was 41.9% in low-income countries versus 87.3% in high-income ones, while some sub-Saharan countries fell below 30% and Australia and Japan exceeded 90%.
The estimates also expose major data gaps: only 67 of 194 countries had observed registry survival data, including just 1 of 25 low-income countries, forcing WHO to rely heavily on modeling in many settings.
WHO said the disparities reflect unequal access to early diagnosis, surgery, radiotherapy and medicines, threatening its goal of cutting breast cancer mortality 2.5% a year and saving 2.5 million lives by 2040.
Why does a woman's breast cancer survival depend more on her passport than her biology?
What single intervention could most rapidly close the deadly survival gap between rich and poor nations?
Closing the Survival Gap: Addressing Global Disparities in Breast Cancer Outcomes and Access to Care
Overview
The global cancer burden is rising sharply, with 20.6 million new cases and 9.8 million deaths reported in 2024, and projections showing a 67% increase in new cases by 2050. These alarming figures put immense pressure on health systems and highlight the urgent need for effective strategies, especially for common cancers like breast cancer. In response, the World Health Organization launched the Global Breast Cancer Initiative in 2021 to address these challenges. This initiative aims to reduce breast cancer mortality and underscores the importance of improving early detection, treatment, and access to care worldwide.